Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders - Quiz - MDSpire

Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders

  • By

  • David T. Liebers

  • Tianshe He

  • Rebecca A. Betensky

  • Chunlei Zheng

  • Kaitlin N. Swinnerton

  • Sean Jacobson

  • Linden Huhmann

  • Mary T. Brophy

  • Nhan V. Do

  • Paola Gilsanz

  • Ricardo S. Osorio

  • Nunzio Pomara

  • Antonio Convit

  • Donald C. Goff

  • Dan V. Iosifescu

  • Nathanael R. Fillmore

  • Jaime Ramos-Cejudo

  • June 30, 2026

  • 0 min

Share

Original Source(s)

Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders

  • by David T. Liebers, Tianshe He, Rebecca A. Betensky, Chunlei Zheng, Kaitlin N. Swinnerton, Sean Jacobson, Linden Huhmann, Mary T. Brophy, Nhan V. Do, Paola Gilsanz, Ricardo S. Osorio, Nunzio Pomara, Antonio Convit, Donald C. Goff, Dan V. Iosifescu, Nathanael R. Fillmore, Jaime Ramos-Cejudo

  • June 30, 2026

Related Content

Gender-specific symptom outcomes on cariprazine treatment: a 12-month naturalistic longitudinal follow-up study in schizophrenia

Tracking the dynamic breakdown of contextual coherence in schizophrenia using language models

Multi-modal deep learning model for bipolar depression adolescents with verbal auditory hallucinations